Many voluntary health organizations fund translational research. An increasing number of these organizations are looking at venture philanthropy as a critical way to advance their missions of helping patients and working to cure disease. A wide range of participants gathered on October 3, 2008 at the Beckman Center of the National Academies of Science for a workshop titled "Venture Philanthropy Strategies Used by Patient Organizations to Support Translational Research." Participants with experience in venture philanthropy shared their experiences and lessons learned in order to improve efficiency and effectiveness in translational research.
1 Front Matter; 2 Introduction; 3 1 Getting Started in Translational Research; 4 2 Models for Building a Translational Research Program; 5 3 Legal, Accounting, and Process Issues; 6 4 Partnerships, Data Sharing, and Intellectual Property; 7 5 Communications; 8 Conclusion; 9 Appendix A: References; 10 Appendix B: Workshop on Venture Philanthropy Strategies Used by Patient Organizations to Support Translational Research; 11 Appendix C: Workshop Attendees; 12 Appendix D: Biographical Sketches of Invited Speakers, Planning Committee Members, and Staff
National Research Council, Division of Behavioral and Social Sciences and Education, Institute of Medicine, and Families Board on Children, Youth, Steve Olson
Institute of Medicine, Board on the Health of Select Populations, and Transgender Health Issues and Research Gaps and Opportunities Committee on Lesbian, Gay, Bisexual
Institute of Medicine, Board on Population Health and Public Health Practice, Division of Health Promotion and Disease Prevention, Division of International Health
Institute of Medicine, Committee to Develop Methods Useful to the Department of Veteran Affairs in Estimating Its Physician Requirements, Joseph Lipscomb
Institute of Medicine, Board on Health Sciences Policy, Forum on Medical and Public Health Preparedness for Catastrophic Events, Theresa Wizemann, Megan Reeve, Bruce Altevogt
Institute of Medicine, Board on Health Sciences Policy, Forum on Medical and Public Health Preparedness for Catastrophic Events, Matthew Hougan, Lori Nadig, Clare Stroud, Bruce M. Altevogt
Institute of Medicine, Board on Health Care Services, Board on Health Sciences Policy, Forum on Medical and Public Health Preparedness for Catastrophic Events, Bruce Altevogt, Bradley Eckert, Theresa Wizemann, Megan Reeve
Institute of Medicine, Board on Health Sciences Policy, Forum on Medical and Public Health Preparedness for Catastrophic Events, Bruce M. Altevogt, Clare Stroud, Lori Nadig
Institute of Medicine, Board on Health Sciences Policy, Forum on Medical and Public Health Preparedness for Catastrophic Events, Miriam Davis, Megan Reeve, Bruce Altevogt
Institute of Medicine, Board on Health Sciences Policy, Forum on Medical and Public Health Preparedness for Catastrophic Events, Bruce M. Altevogt, Lori Nadig, Clare Stroud
Institute of Medicine, Board on Health Sciences Policy, Forum on Medical and Public Health Preparedness for Catastrophic Events, Matthew Hougan, Lori Nadig, Bruce M. Altevogt, Clare Stroud
Institute of Medicine, Board on Health Sciences Policy, Forum on Medical and Public Health Preparedness for Catastrophic Events, Bruce Altevogt, Megan Reeve, Theresa Wizemann